It is evident that the increase of AFP, AFP-L3, and ALT levels in serum and AFP-L3/AFP ratio are potential precursors of HCC; thus regular monitoring of these markers seems necessary in hepatic cirrhosis patients. The gene discussed is GPT; the disease is hepatocellular carcinoma.